Skip to main content

Articles

Page 1 of 61

  1. The role of leukocytes and systemic inflammation indicators in predicting the severity and mortality of inflammatory diseases has been well reported, such as the neutrophil to lymphocyte ratio (NLR), platelet ...

    Authors: Saeed Hosseninia, Hassan Ghobadi, Kara Garjani, Seyed Amir Hossein Hosseini and Mohammad Reza Aslani
    Citation: BMC Pulmonary Medicine 2023 23:107
  2. Chronic obstructive pulmonary disease (COPD) is a complicated chronic inflammatory disease. It is important to investigate the characteristics of acute exacerbation of COPD to develop new therapeutic strategies.

    Authors: Shengchuan Feng, Yuqiong Yang, Fengyan Wang, Weijuan Shi, Jiaxuan Xu, Guoyan Tang, Jiaxing Xie, Nanshan Zhong, Zhenyu Liang and Rongchang Chen
    Citation: BMC Pulmonary Medicine 2023 23:106
  3. Low muscle mass is common in patients approaching lung transplantation and may be linked to worse post-transplant outcomes. Existing studies assessing muscle mass and post-transplant outcomes include few patie...

    Authors: Ann L Jennerich, Lois Downey, Christopher H Goss, Siddhartha G Kapnadak, Joseph B Pryor and Kathleen J Ramos
    Citation: BMC Pulmonary Medicine 2023 23:105
  4. Primary muscular disorders (metabolic myopathies, including mitochondrial disorders) are a rare cause of dyspnea. We report a case of dyspnea caused by a mitochondrial disorder with a pattern of clinical findi...

    Authors: Ralf Ewert, Mohamed A. Elhadad, Dirk Habedank, Alexander Heine and Beate Stubbe
    Citation: BMC Pulmonary Medicine 2023 23:104
  5. Although a relationship between chronic obstructive pulmonary disease (COPD) and dementia has been reported, the initial severity upon emergency department (ED) visits and the medications used have not been we...

    Authors: Kuo-Hua Chia, Yao-Yuan Chang, Tren-Yi Chen, Pei-You Hsieh, Cheng-Chieh Huang, Tsung-Han Lee, Cheng Hsu Chen, Wen-Liang Chen, Chu-Chung Chou and Yan-Ren Lin
    Citation: BMC Pulmonary Medicine 2023 23:103
  6. The clinical characteristics of Klebsiella pneumoniae (KP) pneumonia and KP bloodstream infection (KP-BSI) are often reported, while the risk factors for KP pneumonia developing into secondary KP-BSI (KP-pneumoni...

    Authors: Juan Chen, Jiahui Li, Fangfang Huang, Junjie Fang, Yang Cao, Kai Zhang, Hongwei Zhou, Jiachang Cai, Wei Cui, Chensong Chen and Gensheng Zhang
    Citation: BMC Pulmonary Medicine 2023 23:102
  7. Chronic obstructive pulmonary disease (COPD) is one of the major causes of mortality worldwide and also reports high morbidity rates and the global burden COPD has continued to rise over the last several decad...

    Authors: Isabel Martínez-Pérez, Verónica González-Iglesias, Valentín Rodríguez Suárez and Ana Fernández-Somoano
    Citation: BMC Pulmonary Medicine 2023 23:101
  8. Respiratory symptoms are the earliest clinical manifestation of Talaromyces marneffei (TM) infection. In this study, we aimed to improve the early identification of TM infection in human immunodeficiency virus (H...

    Authors: Qin Yang, Yue Wu, Xiaonan Li, Yanmin Bao, Wenjian Wang and Yuejie Zheng
    Citation: BMC Pulmonary Medicine 2023 23:100
  9. Sex-related differences in cancer epidemiology, tumor biology, immune system activity, and pharmacogenomics have been suggested to be important considerations for precision cancer control. Here we elucidated s...

    Authors: Xuetao Li, Shuquan Wei, Liaoyuan Deng, HongYan Tao, Mingkai Liu, Ziwen Zhao, Xin Du, Yujun Li and Jun Hou
    Citation: BMC Pulmonary Medicine 2023 23:99
  10. Fibrosing interstitial lung disease (F-ILD) is a major public health concern due to its poor prognosis. Recent clinical evidence shows that antifibrotic approaches such as pirfenidone and nintedanib provide be...

    Authors: Kyung-In Joung, Hyemin Park, Sunyoung Park, Ju-Young Shin and Yong Hyun Kim
    Citation: BMC Pulmonary Medicine 2023 23:98
  11. Despite a high paediatric tuberculosis (TB) burden globally, sensitive and specific diagnostic tools are lacking. In addition, no data exist on the impact of pulmonary TB on long-term child lung health in low-...

    Authors: Isabelle Dewandel, Margaret van Niekerk, Elisabetta Ghimenton-Walters, Megan Palmer, Michaile G. Anthony, Carla McKenzie, Rolanda Croucamp, Galit Alter, Anne-Marie Demers, Gert van Zyl, Mathilda Claassen, Pierre Goussard, Ruan Swanepoel, Graeme Hoddinott, Corne Bosch, Rory Dunbar…
    Citation: BMC Pulmonary Medicine 2023 23:97
  12. Asthma is a diverse disease with various etiologic bases. Severe asthma can be associated with increased mortality, hospitalization, and decreased quality of life for asthma patients. High blood eosinophil cou...

    Authors: Yenealem Solomon, Birhanemaskal Malkamu, Ayenew Berhan, Tahir Eyayu, Andargachew Almaw, Biruk Legese and Berhanu Woldu
    Citation: BMC Pulmonary Medicine 2023 23:96
  13. Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease characterized by alveolar epithelial cell injury and lung fibroblast overactivation. At present, only two drugs are appro...

    Authors: Yang Miao, Yanhua Wang, Zhun Bi, Kai Huang, Jingjing Gao, Xiaohe Li, Shimeng Li, Luqing Wei, Honggang Zhou and Cheng Yang
    Citation: BMC Pulmonary Medicine 2023 23:94
  14. We aimed to identify new classes in acute respiratory distress syndrome (ARDS) using physiological and clinical variables and to explore heterogeneity in the effects of glucocorticoid therapy between classes.

    Authors: Qingbo Liao, Yufan Pu, Xiaoer Jin, Zhiwei Zhuang, Xiaowen Xu, Xiaoqiang Ren, Gaoqing Liu and Qi Ding
    Citation: BMC Pulmonary Medicine 2023 23:92
  15. Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive disease of the lung. How to build a typical human mimicking animal model has been a challenge. Thus, to reveal the mechanism and to make it useful ...

    Authors: Aman Gul, Fangyong Yang, Cong Xie, Wenjing Du, Nabijan Mohammadtursun, Bin Wang, Jingjing Le and Jingcheng Dong
    Citation: BMC Pulmonary Medicine 2023 23:91
  16. Small airway dysfunction (SAD), a hallmark of early lung function abnormality, is a major component of several chronic respiratory disorders. The role of SAD in patients with connective tissue disease-related ...

    Authors: Linrui Xu, Giacomo Sgalla, Faping Wang, Min Zhu, Liangyuan Li, Ping Li, Qibing Xie, Xiaoyan Lv, Jianqun Yu, Gang Wang, Huajing Wan, Luca Richeldi and Fengming Luo
    Citation: BMC Pulmonary Medicine 2023 23:90
  17. There are regional differences in the effect of green space on mortality of Chronic obstructive pulmonary disease (COPD). We conduct an ecological study, using the administrative divisions of Chongqing townshi...

    Authors: Aiping Gou, Guanzheng Tan, Xianbin Ding, Jiangbo Wang, Yan Jiao, Chunyan Gou and Qiang Tan
    Citation: BMC Pulmonary Medicine 2023 23:89
  18. Recently, deaths due to mucormycosis in immunocompromised hosts have increased; however, the clinical and pathological features of mucormycosis are not fully understood, especially in view of the associated hi...

    Authors: Masanori Harada, Kazuyo Yasuda, Kazumi Uruchida, Ryoma Yamashita, Keisuke Morikawa, Yutaro Ito, Eisuke Mochizuki, Shun Matsuura, Masaru Tsukui and Naoki Koshimizu
    Citation: BMC Pulmonary Medicine 2023 23:88
  19. Massive hemoptysis is a life-threatening condition that requires immediate treatment. This study aimed to retrospectively analyze the outcome of bronchial artery embolization (BAE) for massive hemoptysis, as w...

    Authors: Hui Li, Xu Ding, Shuo Zhai and Kun Gao
    Citation: BMC Pulmonary Medicine 2023 23:87
  20. Maximal mid-expiratory flow (MMEF) is an earlier predictor of chronic obstructive pulmonary disease (COPD) development than forced expiratory volume in 1 s (FEV1). Changes of lung structure in patients with MMEF ...

    Authors: Yuling Yang, Haiyan Ge, Jinjuan Lu, Xuemei Huang, Kun Wang, Liang Jin, Lin Qi and Ming Li
    Citation: BMC Pulmonary Medicine 2023 23:86
  21. Studies have indicated that hospitalized COVID-19 patients benefit from anticoagulation therapy in terms of survival; however, there is an ongoing controversy over the optimum anticoagulant dosage. This study ...

    Authors: Abel Girma Tessema, Zekarias Masresha Mengiste, Tsegaye Gebreyes Hundie, Hailemichael Getachew Yosef, Dawit Kebede Huluka, Abebaw Bekele Seyoum, Hannibal Kassahun Abate and Rawleigh Craig Howe
    Citation: BMC Pulmonary Medicine 2023 23:85
  22. The pathophysiology, evolution, and associated outcomes of post-COVID dyspnea remain unknown. The aim of this study was to determine the prevalence, severity, and predictors of dyspnea 12 months following hosp...

    Authors: Japnam S. Grewal, Christopher Carlsten, James C. Johnston, Aditi S. Shah, Alyson W. Wong and Christopher J. Ryerson
    Citation: BMC Pulmonary Medicine 2023 23:84
  23. Latent tuberculosis (TB) infection has been known as a seedbed for TB disease later in life. The interruption from latent TB infection to TB disease can be done through TB preventive treatment (TPT). In Cambod...

    Authors: Yom An, Alvin Kuo Jing Teo, Chan Yuda Huot, Sivanna Tieng, Kim Eam Khun, Sok Heng Pheng, Chhenglay Leng, Serongkea Deng, Ngak Song, Daisuke Nonaka and Siyan Yi
    Citation: BMC Pulmonary Medicine 2023 23:83
  24. Rosai-Dorfman disease (RDD) is a rare benign non-langerhans cell histiocytosis, mainly involving lymph nodes and skin. It is even rarer occurring only in central airway of lung and in diffuse form. Central air...

    Authors: Lei Wu, Yan Zhang, Xiaoya Guo, Xing Tang, Keke Xin, Li Yang, Zhe Wang, Wen Jian and Feng Zhao
    Citation: BMC Pulmonary Medicine 2023 23:82
  25. The gold-standard method for establishing a microbiological diagnosis of COVID-19 is reverse-transcriptase polymerase chain reaction (RT-PCR). This study aimed to evaluate the accuracy, sensitivity, specificit...

    Authors: Mirella Cristine Oliveira, Karoleen Oswald Scharan, Bruna Isadora Thomés, Rafaella Stradiotto Bernardelli, Fernanda Baeumle Reese, Amanda Christina Kozesinski-Nakatani, Cintia Cristina Martins, Suzana Margareth Ajeje Lobo and Álvaro Réa-Neto
    Citation: BMC Pulmonary Medicine 2023 23:81
  26. Primary graft dysfunction (PGD) after lung transplantation (LuTx) contributes substantially to early postoperative morbidity. Both intraoperative transfusion of a large amount of blood products during the surg...

    Authors: Jaromir Vajter, Jiri Vachtenheim Jr, Zuzana Prikrylova, Jan Berousek, Tomas Vymazal, Robert Lischke, Archer Kilbourne Martin and Miroslav Durila
    Citation: BMC Pulmonary Medicine 2023 23:80
  27. With the use of targeted drugs in lung cancer patients, targeted drug-induced interstitial lung disease (ILD) has attracted more and more attention. The incidence, time, and severity of different targeted drug...

    Authors: Qian Zhou, Zhong Hu, Xin Li and Xiaokui Tang
    Citation: BMC Pulmonary Medicine 2023 23:79
  28. The risk of death in sepsis patients with acute respiratory distress syndrome (ARDS) was as high as 20–50%. Few studies focused on the risk identification of ARDS among sepsis patients. This study aimed to dev...

    Authors: Chi Xu, Lei Zheng, Yicheng Jiang and Li Jin
    Citation: BMC Pulmonary Medicine 2023 23:78
  29. To determine the diagnostic accuracy of a nanopore sequencing assay of PCR products from a M. tuberculosis complex-specific region for testing of bronchoalveolar lavage fluid (BALF) samples or sputum samples f...

    Authors: Zhifeng Liu, Yang Yang, Qingfeng Wang, Lei Wang, Wenjuan Nie and Naihui Chu
    Citation: BMC Pulmonary Medicine 2023 23:77
  30. CT Severity Score (CT-SS) can be used to assess the extent of severe coronavirus disease 19 (COVID-19) pneumonia. Follow-up CT-SS in patients surviving COVID-19-associated hyperinflammation and its correlation...

    Authors: Marlou THF Janssen, Mark GH Thijssen, Jasenko Krdzalic, Michiel HM Gronenschild, Sofia Ramiro, César Magro-Checa, Robert BM Landewé and Rémy LM Mostard
    Citation: BMC Pulmonary Medicine 2023 23:74
  31. Pneumocystis jirovecii pneumonia (PJP) is one of the most common opportunistic infections in immunocompromised patients. However, the accurate prediction of the development of PJP in non-HIV immunocompromised pat...

    Authors: Liping Huang, Shuyun Xu, Zhimin Huang, Yusheng Chen, Nengluan Xu and Baosong Xie
    Citation: BMC Pulmonary Medicine 2023 23:72
  32. Ablation of malignant pulmonary nodules is a novel therapeutic option for patients who cannot undergo surgery. Current transthoracic approaches cause pneumothorax and/or bleeding in a significant number of cases.

    Authors: Dániel Hammer, Lilla Büdi, Ádám Nagy, Rita Varga and Péter Horváth
    Citation: BMC Pulmonary Medicine 2023 23:71
  33. Acute exacerbation (AE) of interstitial lung disease (ILD) (AE-ILD) is a life-threatening condition and the leading cause of 30-day mortality among patients who underwent pulmonary resection for lung cancer in...

    Authors: Mariko Fukui, Norihiro Harada, Kazuya Takamochi, Takuo Hayashi, Takeshi Matsunaga, Aritoshi Hattori, Izumi Kawagoe and Kenji Suzuki
    Citation: BMC Pulmonary Medicine 2023 23:70
  34. There are scarce data of the costs of non-small cell lung cancer (NSCLC) recurrence in Spain. The objective of this study is to assess the economic burden of disease recurrence, for both locoregional and/or me...

    Authors: Javier De Castro, Amelia Insa, Roberto Collado-Borrell, Vicente Escudero-Vilaplana, Alex Martínez, Elena Fernandez, Ivana Sullivan, Natalia Arrabal, David Carcedo and Alba Manzaneque
    Citation: BMC Pulmonary Medicine 2023 23:69
  35. Although reticulocalbin 3 (Rcn3) has a critical role in alveolar epithelial function as well as in pathogenesis of pulmonary fibrosis, no study has yet examined its diagnostic and prognostic values for interst...

    Authors: Fangping Ding, Liu Yang, Yingfei Wang, Jing Wang, Yingmin Ma and Jiawei Jin
    Citation: BMC Pulmonary Medicine 2023 23:68
  36. Heart failure with reduced ejection fraction (HFrEF) can coexist with chronic obstructive pulmonary disease (COPD), which complicates the clinical situation and worsens quality of life. The study used standard...

    Authors: Chiung-Hung Lin, Jih-Kai Yeh, Ting-Yu Lin, Yu-Lun Lo, Bo-Jui Chang, Jia-Shiuan Ju, Tzu-Hsuan Chiu, Pi-Hung Tung, Yun-Ju Huang and Shu-Min Lin
    Citation: BMC Pulmonary Medicine 2023 23:67
  37. Despite well-known positive effects of pulmonary rehabilitation, access is limited. New strategies to improve access are advocated, including the use of eHealth tools.

    Authors: Pernilla Sönnerfors, Kirsti Skavberg Roaldsen, Sara Lundell, Annika Toots, Karin Wadell and Alexandra Halvarsson
    Citation: BMC Pulmonary Medicine 2023 23:65
  38. The progressive course of pulmonary fibrosis (PPF) is observed with variable prevalence in different entities of fibrosing interstitial lung disease (fILD). PPF is characterised by worsening respiratory sympto...

    Authors: Juergen Behr, Francesco Bonella, Andreas Günther, Dirk Koschel, Antje Prasse, David Pittrow, Jens Klotsche and Michael Kreuter
    Citation: BMC Pulmonary Medicine 2023 23:64
  39. Cuprotosis is a novel and unique form of cell death that is of great value in a variety of cancers. However, the prognostic role of cuprotosis-related genes (CRGs) in lung cancer remains undetermined. We compa...

    Authors: Guangyao Wang, Anqiao Wang, Li Wang, Guanglan Xu, Xiaohua Hong and Fang Fang
    Citation: BMC Pulmonary Medicine 2023 23:63
  40. The importance of multidisciplinary team (MDT) centred on pregnant women with pulmonary hypertension (PH) has been highlighted. However, rare studies have explored its effects on pregnancy outcomes. This study...

    Authors: Wenjie Chen, Jun Luo, Jingyuan Chen, Yusi Chen, Zilu Li, Haihua Qiu and Jiang Li
    Citation: BMC Pulmonary Medicine 2023 23:62
  41. Hypersensitivity pneumonitis (HP) is an immunologically induced inflammation of the lung parenchyma that occurs in susceptible individuals in response to a variety of antigens. Repeated exposures to the causat...

    Authors: Mohamed Abdelhakim Elnady, Reem Elkorashy, Afnan Nabil and Eman Kamal Ibrahim
    Citation: BMC Pulmonary Medicine 2023 23:61
  42. Emerging evidence have demonstrated that oligometastatic non-small cell lung cancer (NSCLC) can achieve clinical benefit from local consolidative therapy. Bone oligometastasis is common in advanced lung cancer...

    Authors: Rongxin Liao, Guangming Yi, Lu Shen, Xiaoyue Zhang, Zaicheng Xu, Yuan Peng and Zhenzhou Yang
    Citation: BMC Pulmonary Medicine 2023 23:59
  43. Since the declaration of COVID-19 as a pandemic, a wide between-country variation was observed regarding in-hospital mortality and its predictors. Given the scarcity of local research and the need to prioritiz...

    Authors: Sahar Kandil, Ayman I. Tharwat, Sherief M. Mohsen, Mai Eldeeb, Waleed Abdallah, Amr Hilal, Hala Sweed, Mohamed Mortada, Elham Arif, Tarek Ahmed, Ahmed Elshafie, Tarek Youssef, Mohamed Zaki, Yasmin El-Gendy, Essam Ebied, Safwat Hamad…
    Citation: BMC Pulmonary Medicine 2023 23:57

Annual Journal Metrics

  • Citation Impact
    3.320 - 2-year Impact Factor (2021)
    3.723 - 5-year Impact Factor (2021)
    1.229 - SNIP (Source Normalized Impact per Paper)
    0.902 - SJR (SCImago Journal Rank)

    Speed
    41 days to first decision for all manuscripts (Median)
    58 days to first decision for reviewed manuscripts only (Median)

    Usage 
    2,041,849 Downloads (2021)
    1,235 Altmetric mentions (2021)

    Transparency and Openness
    TOP Factor Score - 9

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal